SE510643C2 - Termodynamiskt stabil omeprazol natrium form B - Google Patents

Termodynamiskt stabil omeprazol natrium form B

Info

Publication number
SE510643C2
SE510643C2 SE9702483A SE9702483A SE510643C2 SE 510643 C2 SE510643 C2 SE 510643C2 SE 9702483 A SE9702483 A SE 9702483A SE 9702483 A SE9702483 A SE 9702483A SE 510643 C2 SE510643 C2 SE 510643C2
Authority
SE
Sweden
Prior art keywords
omeprazole
sodium
omeprazole sodium
sodium form
preparation
Prior art date
Application number
SE9702483A
Other languages
English (en)
Swedish (sv)
Other versions
SE9702483L (sv
SE9702483D0 (sv
Inventor
Anders Gustavsson
Kristina Kjellbom
Ingvar Ymen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9702483A priority Critical patent/SE510643C2/sv
Publication of SE9702483D0 publication Critical patent/SE9702483D0/xx
Priority to KR1019997012236A priority patent/KR100580987B1/ko
Priority to IL13355998A priority patent/IL133559A0/xx
Priority to EP01128973A priority patent/EP1186602A3/en
Priority to RU2000100361/04A priority patent/RU2186778C2/ru
Priority to NZ501929A priority patent/NZ501929A/en
Priority to SI9830388T priority patent/SI0991641T1/xx
Priority to DK98931166T priority patent/DK0991641T3/da
Priority to JP50548499A priority patent/JP3377218B2/ja
Priority to DE69811892T priority patent/DE69811892T2/de
Priority to EP98931166A priority patent/EP0991641B1/en
Priority to PCT/SE1998/001124 priority patent/WO1999000380A1/en
Priority to HU0003017A priority patent/HU227976B1/hu
Priority to PL337735A priority patent/PL190869B1/pl
Priority to EEP199900593A priority patent/EE03613B1/xx
Priority to CA002294614A priority patent/CA2294614C/en
Priority to AU81353/98A priority patent/AU750239B2/en
Priority to TR1999/03270T priority patent/TR199903270T2/xx
Priority to SK1729-99A priority patent/SK283958B6/sk
Priority to CNB988066165A priority patent/CN1134432C/zh
Priority to CZ0469999A priority patent/CZ296723B6/cs
Priority to PT98931166T priority patent/PT991641E/pt
Priority to AT98931166T priority patent/ATE233756T1/de
Priority to ES98931166T priority patent/ES2191944T3/es
Priority to US09/101,081 priority patent/US6207188B1/en
Priority to IDW991685A priority patent/ID24829A/id
Priority to BR9810483-7A priority patent/BR9810483A/pt
Priority to TW087109498A priority patent/TW483758B/zh
Priority to ARP980102857A priority patent/AR013350A1/es
Priority to ZA985317A priority patent/ZA985317B/xx
Priority to EG74298A priority patent/EG24224A/xx
Priority to MYPI98002907A priority patent/MY127871A/en
Priority to SA98190410A priority patent/SA98190410B1/ar
Priority to UA99126959A priority patent/UA58556C2/uk
Publication of SE9702483L publication Critical patent/SE9702483L/xx
Publication of SE510643C2 publication Critical patent/SE510643C2/sv
Priority to IL133559A priority patent/IL133559A/en
Priority to IS5314A priority patent/IS1946B/is
Priority to NO19996440A priority patent/NO318245B1/no
Priority to HK00105459A priority patent/HK1026699A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9702483A 1997-06-26 1997-06-27 Termodynamiskt stabil omeprazol natrium form B SE510643C2 (sv)

Priority Applications (38)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B
CZ0469999A CZ296723B6 (cs) 1997-06-27 1998-06-11 Forma B sodné soli omeprazolu, zpusob její prípravy, farmaceutický prostredek obsahující tuto formua její pouzití
SK1729-99A SK283958B6 (sk) 1997-06-27 1998-06-11 Forma B sodnej soli omeprazolu, spôsob jej prípravy, farmaceutický prípravok s jej obsahom a jej použitie
BR9810483-7A BR9810483A (pt) 1997-06-27 1998-06-11 Forma b de omeprazol-sódico, processos para a preparação daforma b de omeprazol-sódico e de tratamento de distúrbios gastrointestinais formulação farmacêutica, uso da forma b de omeprazol-sódico.
EP01128973A EP1186602A3 (en) 1997-06-26 1998-06-11 Omeprazole sodium salt and its use as anti-ulcer agent
RU2000100361/04A RU2186778C2 (ru) 1997-06-27 1998-06-11 Натриевая соль омепразола формы б, способ ее получения (варианты) и фармацевтический препарат, содержащий натриевую соль омепразола формы б
NZ501929A NZ501929A (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
SI9830388T SI0991641T1 (en) 1997-06-27 1998-06-11 Crystalline form of omeprazole sodium salt
DK98931166T DK0991641T3 (da) 1997-06-27 1998-06-11 Krystallinsk form af omeprazol-natriumsalt
JP50548499A JP3377218B2 (ja) 1997-06-27 1998-06-11 オメプラゾールナトリウム塩
DE69811892T DE69811892T2 (de) 1997-06-27 1998-06-11 Kristalline form von omeprazol-natriumsalz
EP98931166A EP0991641B1 (en) 1997-06-27 1998-06-11 Crystalline form of omeprazole sodium salt
PCT/SE1998/001124 WO1999000380A1 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
HU0003017A HU227976B1 (en) 1997-06-27 1998-06-11 Crystalline form of omeprazole sodium salt monohydrate and pharmaceutical composition containing it
PL337735A PL190869B1 (pl) 1997-06-27 1998-06-11 Sól sodowa omeprazolu, sposób jej wytwarzania, środek farmaceutyczny i zastosowanie soli sodowej omeprazolu
PT98931166T PT991641E (pt) 1997-06-27 1998-06-11 Forma cristalina de sal sodico de omeprazol
CA002294614A CA2294614C (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
IL13355998A IL133559A0 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
TR1999/03270T TR199903270T2 (xx) 1997-06-27 1998-06-11 Omeprazol sodyum tuzu.
KR1019997012236A KR100580987B1 (ko) 1997-06-27 1998-06-11 오메프라졸 나트륨염
CNB988066165A CN1134432C (zh) 1997-06-27 1998-06-11 奥美拉唑钠盐
AU81353/98A AU750239B2 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
EEP199900593A EE03613B1 (et) 1997-06-27 1998-06-11 Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks
AT98931166T ATE233756T1 (de) 1997-06-27 1998-06-11 Kristalline form von omeprazol-natriumsalz
ES98931166T ES2191944T3 (es) 1997-06-27 1998-06-11 Forma cristalina de la sal de sodio de omeprazol.
US09/101,081 US6207188B1 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt
IDW991685A ID24829A (id) 1997-06-27 1998-06-11 Garam natrium omeprazola
TW087109498A TW483758B (en) 1997-06-27 1998-06-15 Omeprazole sodium salt
ARP980102857A AR013350A1 (es) 1997-06-27 1998-06-16 Sal de sodio de omeprazol forma b, proceso para su preparacion, formulacion farmaceutica, y uso de dicha sal para la fabricacion de medicamentos.
ZA985317A ZA985317B (en) 1997-06-27 1998-06-18 Omeprazole sodium salt
EG74298A EG24224A (en) 1997-06-27 1998-06-24 Omeprazole sodium salt
MYPI98002907A MY127871A (en) 1997-06-27 1998-06-26 Omeprazole sodium salt
SA98190410A SA98190410B1 (ar) 1997-06-27 1998-08-19 ملح صوديوم الأوميبرازول
UA99126959A UA58556C2 (uk) 1997-06-27 1998-11-06 Натрій-омепразол в, спосіб одержання натрій-омепразолу в (варіанти) та фармацевтична композиція
IL133559A IL133559A (en) 1997-06-27 1999-12-16 B-shaped omeprazole sodium
IS5314A IS1946B (is) 1997-06-27 1999-12-21 Kristallað form af ómeprasólnatríumsalti
NO19996440A NO318245B1 (no) 1997-06-27 1999-12-23 Omeprazol-natriumsalt
HK00105459A HK1026699A1 (en) 1997-06-27 2000-08-31 Crystalline form of omeprazole sodium salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B

Publications (3)

Publication Number Publication Date
SE9702483D0 SE9702483D0 (sv) 1997-06-27
SE9702483L SE9702483L (sv) 1998-12-28
SE510643C2 true SE510643C2 (sv) 1999-06-14

Family

ID=20407555

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702483A SE510643C2 (sv) 1997-06-26 1997-06-27 Termodynamiskt stabil omeprazol natrium form B

Country Status (35)

Country Link
US (1) US6207188B1 (ko)
EP (2) EP1186602A3 (ko)
JP (1) JP3377218B2 (ko)
KR (1) KR100580987B1 (ko)
CN (1) CN1134432C (ko)
AR (1) AR013350A1 (ko)
AT (1) ATE233756T1 (ko)
AU (1) AU750239B2 (ko)
BR (1) BR9810483A (ko)
CA (1) CA2294614C (ko)
CZ (1) CZ296723B6 (ko)
DE (1) DE69811892T2 (ko)
DK (1) DK0991641T3 (ko)
EE (1) EE03613B1 (ko)
EG (1) EG24224A (ko)
ES (1) ES2191944T3 (ko)
HK (1) HK1026699A1 (ko)
HU (1) HU227976B1 (ko)
ID (1) ID24829A (ko)
IL (2) IL133559A0 (ko)
IS (1) IS1946B (ko)
MY (1) MY127871A (ko)
NO (1) NO318245B1 (ko)
NZ (1) NZ501929A (ko)
PL (1) PL190869B1 (ko)
PT (1) PT991641E (ko)
RU (1) RU2186778C2 (ko)
SA (1) SA98190410B1 (ko)
SE (1) SE510643C2 (ko)
SK (1) SK283958B6 (ko)
TR (1) TR199903270T2 (ko)
TW (1) TW483758B (ko)
UA (1) UA58556C2 (ko)
WO (1) WO1999000380A1 (ko)
ZA (1) ZA985317B (ko)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
GB2324093A (en) 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
WO2000071122A1 (en) * 1999-05-20 2000-11-30 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
EP1706397A4 (en) * 2000-05-15 2007-08-01 Ranbaxy Lab Ltd AMORPHOUS FORM OF OMEPRAZOLE SALTS
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
CA2419067C (en) 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (en) * 2001-06-01 2013-12-04 Pozen, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
EP1556043A1 (en) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphous form of esomeprazole salts
WO2004099181A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
CA2570795C (en) * 2004-06-24 2013-05-28 Astrazeneca Ab Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
US8247566B2 (en) * 2005-06-08 2012-08-21 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
CN101412710B (zh) * 2008-12-16 2010-04-21 海南百那医药发展有限公司 一种奥美拉唑钠化合物及其制法
EP2445344A4 (en) * 2009-06-25 2013-01-23 Pozen Inc METHOD FOR THE TREATMENT OF A PATIENT REQUIRED BY ASPIRIN THERAPY
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102512380B (zh) * 2011-12-20 2013-04-17 海南锦瑞制药股份有限公司 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN102827147B (zh) * 2012-09-13 2013-08-07 山东罗欣药业股份有限公司 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物
CN102871973A (zh) * 2012-10-16 2013-01-16 浙江亚太药业股份有限公司 一种奥美拉唑钠冻干制剂及其制备方法
CN103012371B (zh) * 2013-01-05 2014-02-12 宁辉 奥美拉唑钠结晶化合物、其制备方法及其药物组合物
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物
CN104788426B (zh) * 2015-04-02 2015-12-30 天津大学 一种奥美拉唑钠半水合物及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2719916A1 (de) * 1977-05-04 1978-11-09 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 2,9-dioxatricyclo eckige klammer auf 4,3,1,0 hoch 3,7 eckige klammer zu decanen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
ES2023778A6 (es) * 1990-12-12 1992-02-01 Genesis Para La Investigacion Procedimiento para preparar sales alcalinas del omeprazol
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
DK0723436T3 (da) 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
WO1998040377A1 (en) * 1997-03-07 1998-09-17 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-[[(2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose
EP0968205A1 (en) * 1997-03-07 2000-01-05 A/S GEA Farmaceutisk Fabrik Process for the preparation of 2- (2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
CA2294614A1 (en) 1999-01-07
EP0991641A1 (en) 2000-04-12
DK0991641T3 (da) 2003-05-19
EE03613B1 (et) 2002-02-15
CN1261362A (zh) 2000-07-26
TR199903270T2 (xx) 2000-07-21
HU227976B1 (en) 2012-07-30
EP0991641B1 (en) 2003-03-05
AU8135398A (en) 1999-01-19
MY127871A (en) 2006-12-29
HUP0003017A2 (hu) 2001-06-28
NO996440D0 (no) 1999-12-23
IL133559A (en) 2006-04-10
PT991641E (pt) 2003-06-30
RU2186778C2 (ru) 2002-08-10
CA2294614C (en) 2002-01-08
ES2191944T3 (es) 2003-09-16
IL133559A0 (en) 2001-04-30
AR013350A1 (es) 2000-12-27
UA58556C2 (uk) 2003-08-15
EE9900593A (et) 2000-08-15
EP1186602A2 (en) 2002-03-13
KR20010014165A (ko) 2001-02-26
ATE233756T1 (de) 2003-03-15
SK283958B6 (sk) 2004-06-08
BR9810483A (pt) 2000-09-12
AU750239B2 (en) 2002-07-11
PL190869B1 (pl) 2006-02-28
SE9702483L (sv) 1998-12-28
NZ501929A (en) 2001-06-29
NO996440L (no) 2000-02-08
HK1026699A1 (en) 2000-12-22
WO1999000380A1 (en) 1999-01-07
IS5314A (is) 1999-12-21
PL337735A1 (en) 2000-08-28
DE69811892T2 (de) 2004-03-04
JP2001508805A (ja) 2001-07-03
JP3377218B2 (ja) 2003-02-17
SE9702483D0 (sv) 1997-06-27
TW483758B (en) 2002-04-21
SA98190410B1 (ar) 2006-06-10
HUP0003017A3 (en) 2002-01-28
ID24829A (id) 2000-08-24
NO318245B1 (no) 2005-02-21
DE69811892D1 (de) 2003-04-10
US6207188B1 (en) 2001-03-27
SK172999A3 (en) 2000-07-11
CN1134432C (zh) 2004-01-14
CZ469999A3 (cs) 2000-08-16
EG24224A (en) 2008-11-10
IS1946B (is) 2004-10-13
KR100580987B1 (ko) 2006-05-17
ZA985317B (en) 1999-01-11
EP1186602A3 (en) 2002-03-27
CZ296723B6 (cs) 2006-05-17

Similar Documents

Publication Publication Date Title
SE510643C2 (sv) Termodynamiskt stabil omeprazol natrium form B
AU722839B2 (en) Novel form of S-omeprazole
NO320014B1 (no) Ny krystallinsk form for omeprazol, fremgangsmate for fremstilling derav, omeprazolsammensetning, farmasoytisk formulering samt anvendelse av omeprazolformen.
SE510666C2 (sv) Nya Kristallmodifikationer
UA71594C2 (uk) Калійна сіль (s)-омепразолу, спосіб її отримання, фармацевтична композиція та спосіб лікування шлунково-кишкових порушень
US8658799B2 (en) Process for the preparation of crystalline modifications for use in the preparation of esomeperazole sodium salt
MXPA99011674A (en) Omeprazole sodium salt
CZ426099A3 (cs) Nová forma S-omeprazolu

Legal Events

Date Code Title Description
NUG Patent has lapsed